1.Gullo, F. P., et al. Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. Eur J Clin Microbiol Infect Dis 32, 1377–1391 (2013).
2.Casadevall, A., Coelho, C. & Alanio, A. Mechanisms of Cryptococcus neoformans-Mediated Host Damage. Front Immunol 9, 855 (2018).
3.Garelnabi, M. & May, R. C. Variability in innate host immune responses to cryptococcosis. Mem Inst Oswaldo Cruz 113, e180060 (2018).
4.Konarzewska, P., et al. Phosphatidylserine synthesis is essential for viability in the human fungal pathogen Cryptococcus neoformans. J Biol Chem (2019).
5.Casadevall, A., et al. The capsule of Cryptococcus neoformans. Virulence, 1–10 (2018).
6.<kvir–10–01–1614383.pdf>.
7.<nihms–630296.pdf>.
8.O’Meara, T. R. & Alspaugh, J. A. The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev 25, 387–408 (2012).
9.Grijpstra, J., Gerwig, G. J., Wosten, H., Kamerling, J. P. & de Cock, H. Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans. Eukaryot Cell 8, 1165–1173 (2009).
10.Rathore, S. S., Raman, T. & Ramakrishnan, J. Magnesium Ion Acts as a Signal for Capsule Induction in Cryptococcus neoformans. Frontiers in microbiology 7, 325 (2016).
11.Tefsen, B., et al. Deletion of the CAP10 gene of Cryptococcus neoformans results in a pleiotropic phenotype with changes in expression of virulence factors. Res Microbiol 165, 399–410 (2014).
12.Qishui, O., Ling, J., Ni, L., Bin, Y. & Wen, L. Comparison of real-time florescence quantitative PCR measurements of VAD1 mRNA with three conventional methods in diagnosis and follow-up treatment of Cryptococcus neoformans infection. Mycoses 55, 326–332 (2012).
13.Chang, A. L. & Doering, T. L. Maintenance of Mitochondrial Morphology in Cryptococcus neoformans Is Critical for Stress Resistance and Virulence. MBio 9(2018).
14.Campuzano, A. & Wormley, F. L. Innate Immunity against Cryptococcus, from Recognition to Elimination. J Fungi (Basel) 4(2018).
15.Sato, K., et al. Cryptococcus neoformans Infection in Mice Lacking Type I Interferon Signaling Leads to Increased Fungal Clearance and IL–4-Dependent Mucin Production in the Lungs. PLoS One 10, e0138291 (2015).
16.Mora, D. J., et al. Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapy. PLoS One 12, e0176304 (2017).
17.Liu, T. B., et al. Cryptococcus inositol utilization modulates the host protective immune response during brain infection. Cell Commun Signal 12, 51 (2014).
18.Firacative, C., et al. Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection. Scientific reports 8, 2681 (2018).
19.Leopold Wager, C. M., et al. IFN-gamma immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans. PLoS Pathog 14, e1007358 (2018).
20.Wiesner, D. L., et al. Regulatory T Cell Induction and Retention in the Lungs Drives Suppression of Detrimental Type 2 Th Cells During Pulmonary Cryptococcal Infection. Journal of immunology 196, 365–374 (2016).
21.Paquissi, F. C. Immunity and Fibrogenesis: The Role of Th17/IL–17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis. Frontiers in Immunology 8(2017).
22.Dolff, S., Witzke, O. & Wilde, B. Th17 cells in renal inflammation and autoimmunity. Autoimmun Rev (2018).
23.Movahed, E., et al. Lung-infiltrating T helper 17 cells as the major source of interleukin–17A production during pulmonary Cryptococcus neoformans infection. BMC Immunol 19, 32 (2018).
24.Sharabi, A., et al. Regulatory T cells in the treatment of disease. Nat Rev Drug Discov (2018).
25.Mo, C., Zeng, Z., Deng, Q., Ding, Y. & Xiao, R. Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis. Biomed Pharmacother 108, 177–183 (2018).
26.Lee, G. R. The Balance of Th17 versus Treg Cells in Autoimmunity. Int J Mol Sci 19(2018).
27.Villegas, J. A., Van Wassenhove, J., Le Panse, R., Berrih-Aknin, S. & Dragin, N. An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients. Ann N Y Acad Sci 1413, 154–162 (2018).
28.Zhou, L., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453, 236–240 (2008).